Hyderabad was established as a major biotech and pharmaceutical center and is referred to as India’s pharmaceutical capital as well as “Genome Valley of India”. Telangana is Hyderabad’s capital. Hyderabad is the source of more than 35 percent of India’s drug manufacturing. In the present, Hyderabad is regarded as the world’s largest bulk drug maker. Hyderabad is included in the top 10 list of Pharma states for manufacturing drugs in India with more than 300 Pharma industries situated in the city. You are looking for the latest list of the top 10 Hyderabad Pharma Companies 2025. Here are some of the most reputable companies.
Major pharmaceutical manufacturing companies such as Ranbaxy, Cipla, Dr. Reddy’s Nicolas Piramal and Dabur are moving their units into “Hyderabad Pharma City”. Many drug companies have invested in their operations in Hyderabad. Therefore, it is the perfect time to start your journey into the pharmaceutical business in Hyderabad.
Hyderabad has emerged as a biotech and pharmaceutical hub. It is recognized as India’s pharmaceutical capital as well as “Genome Valley of India”. Telangana is the capital city of Hyderabad and is responsible for more than 35 percent of India’s pharmaceutical manufacturing. In the present, Hyderabad is considered to be the biggest bulk drug producer. The Hyderabad government has included pharmaceuticals as its top priority sector in its recent industrial policy. Based on the information it is evident that about a third of India’s bulk drug production is made in Hyderabad.
List of Top 10 Pharma Companies in Hyderabad
| No. | Company | Contact Number |
|---|---|---|
| 1 | Aurobindo Pharma | +91 40 6672 5000 |
| 2 | Dr. Reddy’s Laboratories | 1800 425 0014 (India customer care) / +91 40 4900 2900 |
| 3 | Divi’s Laboratories | +91 40 6696 6300 |
| 4 | Neuland Laboratories | +91 40 6761 1600 |
| 5 | Biological E. Limited | +91 40 7121 6000 |
| 6 | Granules India | +91 40 6904 3500 |
| 7 | Hetero Healthcare | +91 40 4047 3535 (also toll-free 1800 103 4696) |
| 8 | Excelra | 040 6707 3333 |
| 9 | Aurore Life Sciences | +91 40 6830 3211 |
| 10 | Novartis / GSK | Novartis India: +91 22 5024 3000 — GSK India: +91 22 2495 9595 (toll-free 1800-2222-03) |
1. Aurobindo Pharma
Aurobindo Pharma, located in Hyderabad’s HITEC City, is a leading multinational pharmaceutical company that is widely acknowledged for its vast product portfolio and production capacity. The company has six core therapeutic areas of work – antibiotics, anti-retrovirals (ARVs), cardiovascular, central nervous system (CNS), gastroenterology, and anti-allergic medicines. Globally, the company is located in more than 150 countries and is progressively accumulating a reputation for the supply of high-quality generics at affordable prices. Aurobindo, above all, is the topmost name in the field of ARV, where it supports the AIDS/HIV global programs by providing extremely necessary drugs like abacavir/lamivudine and dolutegravir. Besides, its commitment to biosimilars and injectables is taking its diversified pharma portfolio to an even higher level.
Therapeutic Focus:
- Antibiotics
- Anti-retrovirals (ARVs)
- Cardiovascular (CVS)
- Central Nervous System (CNS)
- Gastroenterology
- Anti-allergics
Key Highlights:
- One of India’s largest pharma exporters
- Major supplier of ARV medicines under global HIV/AIDS programs
- Significant investments in biosimilars and injectables
Key Products:
- ARVs: Abacavir/lamivudine, Dolutegravir, Tenofovir combos
- Antibiotics: Cephalosporins, penicillins
- Biologics: Pegylated Filgrastim
2. Dr. Reddy’s Laboratories
One of the most substantial Indian pharmaceutical houses in the world is Dr. Reddy’s Laboratories. Established in 1984, the company has been a significant player in the healthcare industry manufacturing APIs, biosimilars, vaccines, diagnostics, and more. The company is currently present in over 66 countries across the globe and locally has Reddy’s products in more than 25 therapeutic areas, leading from cancer and digestive health to the skin and heart. Moreover, the company is taking an active part in the research and development of the future medical treatments like stem cell therapy and gene therapy. Unmistakably, innovation and affordability are at the core of Dr. Reddy’s strategy, and the company is at the forefront of the creation of biosimilar versions of the major pharmaceutical products as well as the development of generics for the latest drugs in the treatment of diabetes and cancer.
Therapeutic Focus:
- Oncology
- Gastrointestinal
- Cardiovascular
- Dermatology
- Pain management
- Metabolic disorders
Innovation Areas:
- Cell and gene therapies
- Immuno-oncology
Key Products:
- Branded Generics: 300+ in various markets
- Biosimilars: Pegfilgrastim, Rituximab, Trastuzumab
- Specialty Products: Generic Keytruda (Pembrolizumab-equivalent)
- Obesity Drug: Generic Semaglutide
3. Divi’s Laboratories
Divi’s Laboratories has been the pure-play manufacturer of API, intermediates, and nutraceutical ingredients in the Indian pharmaceutical landscape, which makes it different. The company is a six-decade old enterprise and is mainly celebrated for its globally competitive manufacturing units and their absolute loyalty to the standards and regulations which in turn, have made it a partner with a cluster of the world’s top pharmaceutical companies. Divi’s is operating two significant industrial establishments in India and is available for drumming up the custom synthesis at the large scale. They are engaged in the synthesis of the pharmaceuticals industry-based API/intermediates used for the treatment of various diseases and also on supplying health supplements in the form of carotenoids and vitamins. Their attributes of quality, quantity, and timeliness have made Divi’s one of the biggest pharma companies in India by market capitalization.
Global Positioning:
- Supplies to top Big Pharma companies
- Strong compliance with USFDA, EU-GMP, and PMDA Japan
Manufacturing Scale:
- 2 mega-manufacturing facilities
- World-class custom synthesis services
Key Products:
- APIs: Naproxen, Dextromethorphan
- Intermediates: For anti-inflammatory, anti-epileptic, and antiviral drugs
- Nutraceuticals: Carotenoids, Omega-3s, and vitamins
4. Neuland Laboratories
Neuland Laboratories, founded in 1984, is a research-driven Contract Development and Manufacturing Organization (CDMO) that mainly deals with complex APIs, peptide APIs, and intermediates. The firm serves the markets of the world such as the US, EU, and Japan and is known for its well-managed and innovation-centric facilities. Neuland has the most expertise in peptide chemistry and complex molecules which require high scientific accuracy. Its custom manufacturing services are designed to support pharmaceutical companies from the early-stage development to commercial manufacturing, hence making it a closest partner for high-barrier products. The commitment to R&D and excellence in manufacturing make Neuland a major player in the global CDMO landscape.
Global Focus:
- USA, EU, Japan
- Regulatory compliance with USFDA, PMDA, EDQM
Specialization:
- Peptide synthesis
- Niche and high-barrier APIs
Key Products:
- APIs: For CNS, respiratory, and cardiovascular diseases
- Peptides: Buserelin, Leuprolide
- Intermediates: Custom and complex chemical intermediates
5. Biological E. Limited
Biological E. Limited is among the oldest and one of the most honorable vaccine makers of India, established 1953 . The firm has been at the forefront of the world’s vaccination programs and is a major supplier to global health organizations like UNICEF and WHO. It is the producer of vaccines for children’s diseases, tuberculosis, and COVID-19, with large production capacities that make it possible to manufacture several millions of doses per year. Biological E. was the center of attention when the COVID-19 pandemic broke out with CORBEVAX’s creation, one of the Indian-made vaccines.
The enterprise is also acknowledged for its Pentavalent vaccine which is a combination vaccine for the immunization of five major diseases. In a bit more than 70 years, Biological E is still a mainstay in the battle against disease.
Global Partnerships:
- WHO, UNICEF, GAVI, CEPI
- Supplies to over 100 countries
Notable Contributions:
- One of the first Indian companies to manufacture vaccines
- Developed CORBEVAX – a COVID-19 vaccine
Key Products:
- Pentavalent Vaccine: DTP-Hib-HepB
- COVID-19 Vaccines: CORBEVAX
- TB & Hepatitis B vaccines
- Antisera and antitoxins
6. Granules India
Granules India a company from Hyderabad is a pharmaceutical company that is dedicated to the mass production of API, pharmaceutical formulation intermediates (PFIs), and finished dosage forms. It started in 1984 and is one of the few Indian companies that have the vertically integrated manufacturing model which goes all the way from the synthesis of the raw material to the delivery of the final product. The company has been the most successful in the production of high volumes of low priced essential drugs of which it is an exporter to more than 60 countries. Granules is a brand that can be associated with major paracetamol, ibuprofen, metformin, and guaifenesin productions. Along with this, it also provides contract manufacturing services to a number of multinational pharmaceutical companies which is a move that is helping it become a part of the global pharma supply chain that is cost-efficient and a reliable partner.
Global Reach: Exports to 60+ countries
Manufacturing: Vertically integrated across the value chain
Key Products:
- APIs: Paracetamol, Ibuprofen, Metformin, Guaifenesin
- PFIs: Pharmaceutical Formulation Intermediates used by other drugmakers
- Tablets/Capsules: Acetaminophen-based drugs, pain and fever medicines
7. Natco Pharma
Natco Pharma is a specialty pharmaceutical company which has created its halo by offering affordable access to high-cost drugs, mainly in oncology, cardiology, and diabetology. The company, which was established in 1981, has gone a long way by patent challenges and launching low-priced versions of high-priced cancer drugs such as imatinib and lenalidomide. Natco is engaged in both the API and finished formulations areas, thus catering to the markets of India and abroad. The company has also spread its wings into agrochemicals with the aim of making farming inputs more accessible. Natco is considered to be a leader in the pharmaceutical field due to its social commitment, intellectual property strategy, and patient-centric innovation.
Global Impact:
- Known for launching affordable alternatives to expensive cancer drugs
- Engaged in US and Canada generics markets
Notable Achievements:
- Challenged patents of major global drugs to offer affordable versions
- Active in crop protection and agrochemicals (new vertical)
Key Products:
- Oncology Generics: Imatinib (Glivec generic), Lenalidomide (Revlimid generic)
- Cardio-diabetic drugs
- Hepatitis C drugs
8. Hetero Healthcare Limited
Hetero Healthcare is the subsidiary of Hetero Group and is a leader in the Indian pharmaceutical sector, specifically in generics and APIs. The firm is recognized for its major contribution to the globe in the battle against HIV/AIDS, and it holds one of the largest anti-retroviral drug portfolios. During the COVID-19 crisis in India, Hetero was on the list of the first companies to introduce generic Remdesivir. Their extensive product line caters to the needs of infectious diseases, antibiotics, cardiovascular and chronic diseases. In addition to a strong presence in the Indian market, Hetero is also well-positioned in more than 100 countries for both exports and international markets, thus, they have made an indispensable contribution in providing cost-effective and high-quality health care products.
Strengths:
- Largest Indian producer of ARVs
- Key role in COVID-19 response with Remdesivir and Favipiravir
Global Presence: Exports to 100+ countries
Domestic Reach: Pan-India retail presence
Key Products:
- Antivirals: Remdesivir, Favipiravir
- Generics: Cardiovascular, anti-diabetics
- Formulations: Capsules, injectables, tablets
9. Excelra
Instead of being a typical pharmaceutical company, Excelra is a data analytics and life sciences research company that helps drug manufacturers take the smarter route in drug development. Excelra, which is located in Hyderabad, excels at giving life science solutions (including bioinformatics, cheminformatics, and real-world data) to pharmaceutical and biotech companies. Their platforms not only speed up drug discovery, but also help in clinical trials’ optimization, and in the restart of using old drugs. GOSTAR®, one of the company’s essential offerings, is a compiled database of small organic compounds that is used by scientists all over the world. Excelra is a company that provides support for pharmaceutical innovation by transforming complicated scientific data into the insights that are easy to follow, hence, a very important but less visible role in the new therapies and medical breakthroughs.
Key Services:
- Drug discovery analytics
- Clinical trial data processing
- Bioinformatics and cheminformatics
- Regulatory data curation
Global Clients:
- Pharma, biotech, CROs, academic researchers
- Supports drug discovery, clinical research, and real-world data analysis
Key Products/Services:
- GOSTAR®: A curated small molecule database
- AI/ML-enabled platforms for drug repurposing and target identification
10. Aurore Life Sciences
Aurore Life Sciences is a young and agile company in the pharmaceutical sector with concentration in the process of development and production of APIs and specialty intermediates. A company with strong R&D capabilities was established in 2016 and is recognized for its shift to the less explored areas of treatment like immunology and allergy. Aurore has notably earned a good standing in top-quality and creative solutions, providing markets under strict regulations with facilities that are GMP certified for manufacturing. Their product range covers the necessary API lifestyle for immunosuppressants such as tacrolimus, hypersensitivity medicines such as montelukast, and other intermediates of high value. The firm comprises contract manufacturing and custom synthesis services, enabling it as a partner for pharmaceutical companies dispatching diversified chemical solutions.
Strengths:
- Strong in R&D-driven innovation
- GMP-compliant facilities with exports to regulated markets
Therapeutic Focus:
- Immunology
- Anti-allergy
- CNS and oncology (emerging segments)
Key Products:
- Immunosuppressants: Tacrolimus, Sirolimus
- Anti-allergics & other APIs: Montelukast, Fexofenadine
- Custom synthesis & contract manufacturing